3,3′,4′,5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 9, 2009, Pages 720-728

  Mao, Zhangfan ^a   Liang, Yuanxin ^b   Du, Xinling ^b   Sun, Zongquan ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiotensin II; Apoptosis; Cardiac hypertrophy; NADPH oxidase; Pentamethylquercetin; Quercetin; Reactive oxygen species

Indexed keywords

3,3',4',5,7 PENTAMETHYLQUERCETIN; ANGIOTENSIN II; CARDIOVASCULAR AGENT; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P47; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; 3,3',4',5,7-PENTAMETHYLQUERCETIN; CARDIOTONIC AGENT; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HEART LEFT VENTRICLE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CARDIOMEGALY; CHEMICAL STRUCTURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CARDIOMEGALY; CARDIOTONIC AGENTS; DOWN-REGULATION; GENE EXPRESSION; MALE; MOLECULAR STRUCTURE; NADPH OXIDASE; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70349272831     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-069     Document Type: Article

References (40)

1. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation, 105(3): 293-296. doi:10.1161/hc0302.103712. PMID:11804982.
2. Benkirane, K., Viel, E.C., Amiri, F., and Schiffrin, E.L. 2006. Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo. Hypertension, 47(1): 102-108. doi:10.1161/01.HYP. 0000196728.05488.c3. PMID:16344371. (Pubitemid 43177822)
3. Buhler, V. 2005. Polyvinylpyrrolidone excipients for pharmaceuticals: povidone, crospovidone and copovidone. Springer, New York.
4. Byrne, J.A., Grieve, D.J., Bendall, J.K., Li, J.M., Gove, C., Lambeth, J.D., et al. 2003. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93(9): 802-805. doi:10.1161/01.RES.0000099504.30207.F5. PMID:14551238.
5. Cai, H., Griendling, K.K., and Harrison, D.G. 2003. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24(9): 471-478. doi:10.1016/S0165-6147(03)00233-5. PMID:12967772.
6. Chen, Y., Hou, M., Li, Y., Traverse, J.H., Zhang, P., Salvemini, D., et al. 2005. Increased superoxide production causes coronary endothelial dysfunction and depressed oxygen consumption in the failing heart. Am. J. Physiol. Heart Circ. Physiol. 288(1): H133-H141. doi:10.1152/ajpheart.00851. 2003. PMID:15598865.
7. Doughan, A.K., Harrison, D.G., and Dikalov, S.I. 2008. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102(4): 488-496. doi:10.1161/circresaha.107.162800. PMID:18096818.
8. Graf, B.A., Ameho, C., Dolnikowski, G.G., Milbury, P.E., Chen, C.Y., and Blumberg, J.B. 2006. Rat gastrointestinal tissues metabolize quercetin. J. Nutr. 136(1): 39-44. PMID:16365056. (Pubitemid 43156482)
9. Graiani, G., Lagrasta, C., Migliaccio, E., Spillmann, F., Meloni, M., Madeddu, P., et al. 2005. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension, 46(2): 433-440. doi:10.1161/01.HYP.0000174986.73346.ba. PMID:15998704. (Pubitemid 41099181)
10. Hämäläinen, M., Nieminen, R., Vuorela, P., Heinonen, M., and Moilanen, E. 2007. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007: 45673. doi:10.1155/2007/45673. PMID:18274639. (Pubitemid 47388729)
11. Hill, M.F., and Singal, P.K. 1997. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation, 96(7): 2414-2420. PMID:9337218. (Pubitemid 27425850)
12. Huxley, R.R., and Neil, H.A. 2003. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 57(8): 904-908. doi:10.1038/sj.ejcn.1601624. PMID:12879084.
13. Ikizler, M., Erkasap, N., Dernek, S., Kural, T., and Kaygisiz, Z. 2007. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment. Anadolu Kardiyol. Derg. 7(4): 404-410. PMID:18065337.
14. Jiang, L., Huang, Y., Yuasa, T., Hunyor, S., and dos Remedios, C.G. 1999. Elevated DNase activity and caspase expression in association with apoptosis in failing ischemic sheep left ventricles. Electrophoresis, 20(10): 2046-2052. doi:10.1002/(SICI)1522-2683(19990701)20:10〈2046::AID-ELPS2046〉3.0. CO;2-C. PMID:10451113.
15. Kajstura, J., Cigola, E., Malhotra, A., Li, P., Cheng, W., Meggs, L.G., and Anversa, P. 1997. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell. Cardiol. 29(3): 859-870. doi:10.1006/jmcc.1996. 0333. PMID:9152847.
16. Kaul, N., Siveski-Iliskovic, N., Hill, M., Slezak, J., and Singal, P.K. 1993. Free radicals and the heart. J. Pharmacol. Toxicol. Methods, 30(2): 55-67. doi:10.1016/1056-8719(93)90008-3. PMID:8298182.
17. Kawada, N., Imai, E., Karber, A., Welch, W.J., and Wilcox, C.S. 2002. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J. Am. Soc. Nephrol. 13(12): 2860-2868. doi:10.1097/01.ASN.0000035087.11758.ED. PMID:12444204.
18. Kawahara, T., Quinn, M.T., and Lambeth, J.D. 2007. Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol. Biol. 7(1): 109. doi:10.1186/1471-2148-7-109. PMID:17612411.
19. Lee, D.H., Sim, G.S., Kim, J.H., Lee, G.S., Pyo, H.B., and Lee, B.C. 2007. Preparation and characterization of quercetin-loaded polymethyl methacrylate microcapsules using a polyol-in-oil-in-polyol emulsion solvent evaporation method. J. Pharm. Pharmacol. 59(12): 1611-1620. doi:10.1211/jpp.59. 12.0002. PMID:18053322.
20. Leri, A., Claudio, P.P., Li, Q., Wang, X., Reiss, K., Wang, S., et al. 1998. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest. 101(7): 1326-1342. doi:10.1172/JCI316. PMID:9525975.
21. Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B., and Ho, K.K. 1996. The progression from hypertension to congestive heart failure. JAMA, 275(20): 1557-1562. doi:10.1001/jama.275.20.1557. PMID:8622246. (Pubitemid 26154241)
22. Li, Z., Bing, O.H., Long, X., Robinson, K.G., and Lakatta, E.G. 1997. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am. J. Physiol. 272(5 Pt 2): H2313-H2319. PMID:9176300.
23. Li, J.M., Gall, N.P., Grieve, D.J., Chen, M., and Shah, A.M. 2002. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension, 40(4): 477-484. doi:10.1161/01.HYP.0000032031.30374.32. PMID:12364350.
24. Li, S., Wang, Z., Sang, S., Huang, M.T., and Ho, C.T. 2006. Identification of nobiletin metabolites in mouse urine. Mol. Nutr. Food Res. 50(3): 291-299. doi:10.1002/mnfr.200500214. PMID:16521176.
25. Lin, N., Sato, T., Takayama, Y., Mimaki, Y., Sashida, Y., Yano, M., and Ito, A. 2003. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem. Pharmacol. 65(12): 2065-2071. doi:10.1016/S0006-2952(03)00203-X. PMID:12787887.
26. Loke, W.M., Proudfoot, J.M., Stewart, S., McKinley, A.J., Needs, P.W., Kroon, P.A., et al. 2008. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem. Pharmacol. 75(5): 1045-1053. doi:10.1016/j.bcp.2007.11.002. PMID:18096136.
27. Misao, J., Hayakawa, Y., Ohno, M., Kato, S., Fujiwara, T., and Fujiwara, H. 1996. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation, 94(7): 1506-1512. PMID:8840837. (Pubitemid 26320251)
28. Mollnau, H., Wendt, M., Szöcs, K., Lassègue, B., Schulz, E., Oelze, M., et al. 2002. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90(4): E58-E65. doi:10.1161/01.RES.0000012569.55432.02. PMID:11884382.
29. Murakami, A., Koshimizu, K., Ohigashi, H., Kuwahara, S., Kuki, W., Takahashi, Y., et al. 2002. Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with luteolin. Biofactors, 16(3-4): 73-82. doi:10.1002/biof.5520160303. PMID:14530595. (Pubitemid 37260274)
30. Robinson, B.V., Sullivan, F.M., Borzelleca, J.F., and Schwartz, S.L. 1990. PVP: a critical review of the kinetics and toxicology of polyvinylpyrrolidone (povidone). Lewis, Michigan.
31. Rueckschloss, U., Quinn, M.T., Holtz, J., and Morawietz, H. 2002. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 22(11): 1845-1851. doi:10.1161/01.ATV.0000035392.38687.65. PMID:12426214.
32. Sánchez, M., Galisteo, M., Vera, R., Villar, I.C., Zarzuelo, A., Tamargo, J., et al. 2006. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J. Hypertens. 24(1): 75-84. PMID:16331104. (Pubitemid 41818091)
33. phox induced by angiotensin II in rat aorta. J. Nutr. 137(4): 910-915. PMID:17374653.
34. Sawyer, D.B., Siwik, D.A., Xiao, L., Pimentel, D.R., Singh, K., and Colucci, W.S. 2002. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34(4): 379-388. doi:10.1006/jmcc.2002.1526. PMID:11991728.
35. Simko, F., Simko, J., and Fabryova, M. 2003. ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle. Cardiovasc. Drugs Ther. 17(3): 287-290. doi:10.1023/A:1026215712983. PMID:14669746.
36. Ushio-Fukai, M. 2006. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71(2): 226-235. doi:10.1016/j.cardiores.2006.04.015. PMID:16781692.
37. van Zanden, J.J., van der Woude, H., Vaessen, J., Usta, M., Wortelboer, H.M., Cnubben, N.H., and Rietjens, I.M. 2007. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem. Pharmacol. 74(2): 345-351. doi:10.1016/j.bcp.2007.04.002. PMID:17509533.
38. Wen, X., and Walle, T. 2006. Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica, 36(5): 387-397. doi:10.1080/ 00498250600630636. PMID:16854778. (Pubitemid 43879739)
39. Wu, R., Laplante, M.A., and De Champlain, J. 2004. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J. Hypertens. 22(4): 793-801. doi:10.1097/00004872-200404000-00023. PMID:15126922. (Pubitemid 38543572)
40. Zhang, X.H., Liu, Z.M., He, T., Yang, F., and Jin, M.W. 2008. Effects of pentamethyl quercetin on contractility and electrophysiology of cardiac muscle in guinea pigs [In Chinese]. ACTA Med. Univ. Sci. Technol. Huazhong. 37(6): 757-761.